These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. Struyfs H, Van Broeck B, Timmers M, Fransen E, Sleegers K, Van Broeckhoven C, De Deyn PP, Streffer JR, Mercken M, Engelborghs S. J Alzheimers Dis; 2015 Feb; 45(3):813-22. PubMed ID: 25633670 [Abstract] [Full Text] [Related]
3. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels. Slaets S, Le Bastard N, Martin JJ, Sleegers K, Van Broeckhoven C, De Deyn PP, Engelborghs S. J Alzheimers Dis; 2013 Feb; 36(4):759-67. PubMed ID: 23666174 [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD. J Alzheimers Dis; 2015 Feb; 44(2):525-39. PubMed ID: 25391385 [Abstract] [Full Text] [Related]
5. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Hock C, Golombowski S, Müller-Spahn F, Naser W, Beyreuther K, Mönning U, Schenk D, Vigo-Pelfrey C, Bush AM, Moir R, Tanzi RE, Growdon JH, Nitsch RM. Eur Neurol; 1998 Feb; 39(2):111-8. PubMed ID: 9520072 [Abstract] [Full Text] [Related]
13. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium. Somers C, Struyfs H, Goossens J, Niemantsverdriet E, Luyckx J, De Roeck N, De Roeck E, De Vil B, Cras P, Martin JJ, De Deyn PP, Bjerke M, Engelborghs S. J Alzheimers Dis; 2016 Aug 10; 54(1):383-95. PubMed ID: 27567807 [Abstract] [Full Text] [Related]
14. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration. Rogeberg M, Almdahl IS, Wettergreen M, Nilsson LN, Fladby T. J Proteome Res; 2015 Nov 06; 14(11):4834-43. PubMed ID: 26452689 [Abstract] [Full Text] [Related]
15. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. Alcolea D, Carmona-Iragui M, Suárez-Calvet M, Sánchez-Saudinós MB, Sala I, Antón-Aguirre S, Blesa R, Clarimón J, Fortea J, Lleó A. J Alzheimers Dis; 2014 Nov 06; 42(1):157-67. PubMed ID: 24820015 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein. Marksteiner J, Hinterhuber H, Humpel C. Drugs Today (Barc); 2007 Jun 06; 43(6):423-31. PubMed ID: 17612711 [Abstract] [Full Text] [Related]